Imatinib Tablets Ip 400 Mg

Name: Imatinib Tablets Ip 400 Mg
Brand: BHAVYA ENTERPRISES
Price: 250 INR
Availability: InStock

Price 250 INR/ Pack

Get a Price/Quote

MOQ : 100 Packs

Imatinib Tablets Ip 400 Mg Specification

Pacakaging (Quantity Per Box)
28 Tablets

Life Span
2 years

Dosage Form
Tablet

Indication
Leukemia, GIST

Packaging Type
Box

Salt Composition
Imatinib Mesylate

Brand Name
Imatib

Drug Type
Allopathic

Ingredients
Imatinib Mesylate

Physical Form
Tablet

Function
Anticancer therapy

Recommended For
Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumors

Dosage
400 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
28 Tablets

Storage Instructions
Store below 30C, protect from moisture

ATC Code
L01XE01

Blister Pack
Included

Shape
Capsule-shaped

Patient Group
Cancer patients

Prescription Required
Yes

Color
Light brownish-orange

Oral Administration
Yes

Film Coated
Yes

Imatinib Tablets Ip 400 Mg Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Imatinib Tablets Ip 400 Mg

Imatib Imatinib Tablets IP 400 mg offer an exclusive solution for adults battling chronic myeloid leukemia and gastrointestinal stromal tumors. With favorable reviews and a distinguished track record, these film-coated, light brownish-orange, capsule-shaped tablets present marvelously reliable oral anticancer therapy. Each box contains 28 scarce and sought-after tablets, with a life span of 2 years, securely packaged in blister packs. Trusted across leading healthcare institutions in India, Imatib's soaring efficacy is driven by Imatinib Mesylate, a renowned salt composition in oncology. Prescription required. Store below 30C.

Guidelines and Applications for Imatib Tablets

Imatinib Tablets IP 400 mg must be administered strictly as per physician's direction, orally with water. Mainly recommended for adults suffering from leukemia and gastrointestinal stromal tumors, their application extends to major oncology centers and reputable hospitals. Apart from standard use in chronic myeloid leukemia, they are also employed for gastrointestinal stromal tumors. Always adhere to specified dosage and application areas, ensuring maximum therapeutic benefit under medical supervision.

Market Reach and Exceptional Packaging for Imatinib Tablets

The main domestic market for Imatinib Tablets spans major Indian cities, reflecting a soaring market value attributed to its exclusive therapeutic action. Export markets have seen an uptick, minimizing drop-off rates, as international demand for quality anticancer medication climbs. Each box and blister pack safeguards 28 tablets, ensuring product integrity. Imatib's distinguished packaging standards are indicative of its commitment to quality, making it a favorite both domestically and abroad.

FAQ's of Imatinib Tablets Ip 400 Mg:

Q: How should Imatinib Tablets IP 400 mg be administered?

A: These tablets should be taken orally with water, strictly following the dosage and guidance provided by your physician. They must not be chewed or crushed.

Q: What is the primary use of Imatib Imatinib Tablets IP 400 mg?

A: Imatib is mainly indicated for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors in adult patients.

Q: When is a patient eligible to use Imatinib Tablets IP 400 mg?

A: Eligibility is determined by a physician, generally when diagnosed with specific cancers like chronic myeloid leukemia or GIST, and upon prescription.

Q: Where should Imatinib Tablets be stored to ensure efficacy?

A: Store the tablets below 30C in a dry place, away from moisture, to maintain their effectiveness over the two-year shelf life.

Q: What packaging type does Imatib offer for these tablets?

A: Imatib provides a box containing a blister pack, with 28 tablets securely sealed to prevent exposure and maintain quality throughout storage and transport.

Q: What benefits do Imatinib Tablets offer over standard cancer therapies?

A: Imatinib Tablets are considered exclusive due to their targeted mechanism and favorable outcomes in adult patients suffering from specific cancers, offering distinguished therapeutic results.

Tell us about your requirement